Pholcodine

KUALA LUMPUR, March 23 — The Drug Control Authority (DCA) has cancelled the registrations of and recalled all cough and cold medications containing ...

The Health DG, however, cited the World Health Organization (WHO) that has reported 852 cases of adverse effects linked to the use of pholcodine. Subsequently, it is found that the risk of taking medication containing pholcodine is higher than the benefits. “MOH encourages the public to report any suspected adverse effects to the NPRA. Amongst the reported cases, 42 reports of anaphylactic reaction and 20 reports of anaphylactic shock were recorded. However, amongst the reports received, no reports of anaphylaxis were received.” Pholcodine is an opioid medicine previously approved for use in adults and children to treat non-productive (dry) cough.

KUALA LUMPUR, March 23 — The Ministry of Health (MOH) has issued cancellation and recall on all registered products containing pholcodine.

He said the World Health Organisation (WHO) also reported 852 reports of adverse effects involving the use of pholcodine and of that number 42 reports of an anaphylactic reaction and 20 reports of anaphylactic shock were recorded. “In other words, those who have taken a medicine containing pholcodine (usually a cough medicine) in the past 12 months face a higher risk of experiencing anaphylaxis if they are given muscle relaxants or NMBAs during the full anaesthesia process, for example during surgery,” he said in a statement today. “There is a risk of anaphylaxis (severe and potentially life-threatening allergic reaction) with the use of muscle-relaxant or neuromuscular blocking agents (NMBAs) during the general anaesthesia process, especially to those who have taken medicines containing pholcodine in the past 12 months.

The EU has recommended the withdrawal of medicines containing pholcodine from its market, while the UK recently withdrew certain dry cough products.

HSA is currently reviewing the safety information in totality while taking into consideration its relevance to Singapore," it said. Advertisement

The opioid may trigger sudden, life-threatening allergic reactions in people who later undergo general anaesthetic.

This rare allergic reaction can occur up to a year later... Email [email protected] or call 0860 52 52 00. The country aims to give more recognition to its Indigenous people, who have inhabited the continent for 60,000 years but are not mentioned in the 122-year-old constitution

The report on the adverse cases by the National Pharmaceutical Regulatory Agency comes after the health ministry's directive that the medicine Pholcodine be ...

Connection is secure Checking if the site connection is secure Occasionally, you may see this page while the site ensures that the connection is secure.

KUALA LUMPUR: The Health Ministry has issued a cancellation and recall on all registered products containing pholcodine.